Publications by authors named "R Aronica"

Article Synopsis
  • Digital approaches are seen as valuable in addressing the mental health needs of individuals with schizophrenia and severe mental illness, and an international group was formed to discuss challenges and solutions in this area.
  • The group identified four main challenges: user involvement, methodological issues, regulatory and funding hurdles, and real-world implementation, and provided specific examples and recommendations for each.
  • The consensus includes calls for improved digital mental health research standards, the importance of social factors, and integrating lived experiences into the design and delivery of mental health interventions.
View Article and Find Full Text PDF

Psychosis onset is a transdiagnostic event that leads to a range of psychiatric disorders, which are currently diagnosed through clinical observation. The integration of multimodal biological data could reveal different subtypes of psychosis onset to target for the personalization of care. In this study, we tested the existence of subgroups of patients affected by first-episode psychosis (FEP) with a possible immunopathogenic basis.

View Article and Find Full Text PDF

Major Depressive Disorder (MDD) and Bipolar Disorder Depression (BDD) are common psychiatric illnesses characterized by structural and functional brain alterations and signs of neuroinflammation. In line with the neuroinflammatory pathogenesis of depressive syndromes, recent studies have demonstrated how white matter (WM) microstructural impairments detected by Diffusion Tensor Imaging, are correlated to peripheral immunomarkers in depressed patients. In this context, we performed a comprehensive systematic search on PubMed, Medline and Scopus of the original studies published till June 2022, exploring the association between immunomarkers and WM alteration patterns in patients affected by MDD or BDD.

View Article and Find Full Text PDF

Background: Remdesivir (REM) has shown potent antiviral activity and efficacy in animal models of COVID-19; nevertheless, clinical trials and real-life reports have shown conflicting data on its effectiveness. Aims of the study were to evaluate the impact of remdesivir on I) Intensive Care Unit (ICU) admission, II) need for orotracheal intubation (OTI) and III) in-hospital mortality. Furthermore, we estimated the kinetics of laboratory parameters and assessed the risk factors for in-hospital mortality in the remdesivir population.

View Article and Find Full Text PDF